Truncated leaflet for prosthetic heart valves
US-2024180692-A1 · Jun 6, 2024 · US
US9918832B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9918832-B2 |
| Application number | US-201113189036-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 22, 2011 |
| Priority date | Oct 27, 2006 |
| Publication date | Mar 20, 2018 |
| Grant date | Mar 20, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of treating a biological tissue that enables dry storage of said tissue is disclosed. In one embodiment, the method comprises contacting the biological tissue with a non-aqueous treatment solution comprising a polyhydric alcohol and a C 1 -C 3 alcohol and removing a portion of the treatment solution from the solution-treated biological tissue. Also disclosed is biological tissue prepared using the above process and prosthetic devices made with such tissue.
Opening claim text (preview).
We claim: 1. A sealed package containing a sterilized bioprosthesis comprising: a bioprosthetic heart valve comprising a pliable, elastic, and glutaraldehyde-fixed biological tissue having an interstitial volume comprising glycerol, wherein the biological tissue is coupled to a stent and wherein the bioprosthetic heart valve is treated with a solution comprising 50-90% glycerol and 50-10% ethanol; and the sealed package containing the bioprosthetic heart valve, wherein the sealed package does not contain a liquid storage solution in contact with the bioprosthetic heart valve. 2. The sealed package of claim 1 , wherein the biological tissue is selected from the group consisting of pericardium, aortic and pulmonary roots, tendons, ligaments, skin, facia, peritonium, pleura, and mitral and tricuspid valves. 3. The sealed package of claim 1 , wherein the biological tissue is decellularized. 4. The sealed package of claim 1 , wherein the stent is elastic and the bioprosthetic heart valve is collapsible. 5. The sealed package of claim 1 , wherein the sealed package is sterilized by a gas or by exposure to ionizing radiation. 6. The sealed package of claim 5 , wherein the gas is ethylene oxide.
Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking · CPC title
characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents · CPC title
Manufacturing methods · CPC title
for artificial blood vessels (apparatus for applying cells on a blood vessel prosthesis A61F2/062) · CPC title
characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.